Skip to content
GLP-1 Scorecard
Menu
Graded #126

Navio MD

NavioMD offers compounded tirzepatide ($247/mo) plus brand-name Ozempic ($1,199/mo) and Mounjaro ($1,249/mo).

Visit Navio MDWe may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.
Semaglutide
$345/mo (starting dose, brand-name)
Tirzepatide
$189/mo (starting dose, compounded)
Coverage
48 states
Brand-name
Yes

Weigh Navio MD against the full graded field on the best semaglutide providers scorecard, or line it up against its closest alternatives.

Factor breakdown

Each of the six graded dimensions. See the methodology.

Cost value56/100
Dose & formulation77/100
Clinical oversight87/100
Labs & monitoring54/100
Fulfillment85/100
Contract terms55/100

Strengths

  • LegitScript verified with board-certified providers and US-licensed pharmacies
  • Both compounded and brand-name options
  • 48-state coverage
  • Hours 9am–10pm EST Mon–Sun
  • Transparent tiered pricing: you only pay for your current dose

Where it loses points

  • Not available in Alabama and Mississippi
  • Compounded option is tirzepatide only — no compounded semaglutide listed
  • Also offers women's HRT (broader platform)
  • Pricing is tiered by dose ('as low as'); the entry prices climb as your dose increases

Bottom line — Grade C

Best for: Shoppers who want compounded tirzepatide with brand-name fallback across 48 states.

Ranked #126 of 499 on this scorecard. See our top-scoring pick, CoreAge Rx (#1), for comparison.

Closest on the board

The boards grading nearest Navio MD — the realistic shortlist.

The 21 boards nearest this one

View full scorecard rankings →

Pricing/verification reflect Navio MD's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on Navio MD's site. Not medical advice; see our disclosure.

← Back to the scorecard